A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the ...

The study used large-scale CRISPR gene-editing technology to systematically determine which genes are required as embryonic ...

Like other developing countries, Indonesia is facing a familiar dilemma: how to feed a growing population while protecting ...

Cathie Wood’s latest moves entering 2026 focused on early-stage biotechnology firms while cutting exposure to consumer ...

A new CRISPR breakthrough shows scientists can turn genes back on without cutting DNA, by removing chemical tags that act ...

A new CRISPR approach can control genes without cutting DNA, opening a safer path for treating genetic diseases. A newly ...

As CRISPR moves from lab success to real-world medicine, 2026 will test whether these revolutionary gene-editing therapies ...

Scientists and physicians can better assess precision genome editing technology using a new method made public today by St.

A 10-month-old baby who sparked nationwide headlines after receiving a first-of-its kind gene-editing treatment was released from the hospital this week.

The US Food and Drug Administration (FDA) has cleared GenEditBio Limited’s Investigational New Drug (IND) application to ...

The vast majority of consumers are open to purchasing gene-edited pork, according to new research from Circana, commissioned ...

Cathie Wood is making a massive bet on gene editing, pouring $5.4 billion into companies like Beam Therapeutics while selling ...